MedPath

One-lung Ventilation: Expression of Pulmonary Inflammatory Mediators

Not Applicable
Completed
Conditions
Thoracic Surgery With One-lung Ventilation
Registration Number
NCT00515905
Lead Sponsor
University of Zurich
Brief Summary

One-lung ventilation; organ protection; volatile anesthetics

One-lung ventilation has become a common procedure for thoracoscopic surgery. Two hypothesis will be tested in this study:

1. Are inflammatory mediators increased in the re-ventilated lung after short-period pulmonary collapse?

2. Does Sevoflurane influence the production of inflammatory mediators in the re-inflated lung? Therefore, this study will elucidate the potential protective effect of a volatile anaesthetic (sevoflurane) on the production of inflammatory mediators by the respiratory compartment of the lung, i.e. the alveolar epithelium.

* Trial with immunomodulatory product / biological

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
One-lung ventilation measurement in the re-ventilated lung after short-period pulmonary collapseSep 07
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath